Ten type 1 diabetes advocates chosen for their influence in the diabetes community
Carmel, Ind. May, 1 – Lisa Oberndorfer, executive director and founder of Diabetes Will’s Way (www.diabeteswillsway.com), a nonprofit serving young people in the United States by reducing type 1 diabetes medical costs, is proud to be a winner of The 2019 DiabetesMine Patient Voices Scholarship Contest. Oberndorfer will attend the Innovation Summit held on Nov. 7-8, 2019, at the UCSF Mission Bay biotech conference center.
Oberndorfer was the first diabetes advocated profiled. Read her interview:
According to the contest’s application web page:
DiabetesMine’s Innovation Days bring together informed patient advocates with leading Pharma and medical device leaders, healthcare designers, regulatory experts, clinicians, mobile health experts / visionaries, entrepreneurs, investors, and more.
“I am humbled to receive the DiabetesMine scholarship,” said Oberndorfer. “As a leading provider of diabetes news, DiabetesMine acts as a hub of diabetes information for the families we serve. We are grateful for their work and dedication. I’m excited to learn how I can better serve the diabetes community.”
Diabetes Will’s Way received its 501(c)3 status in April, 2013. The nonprofit organization began after Will Oberndorfer was diagnosed with type 1 diabetes at the age of thirteen. Will quickly began fundraising for JDRF Indianapolis. After raising more than $8,000, Will, his mother, and godmother were driven to launch, what was then known as, Will’s Way.
Diabetes Will’s Way provides two types of grants; a durable medical equipment grant and an emergency cash grant, to children, under the age of 26, who are suffering from type 1 diabetes and have insurance.